Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in Egyptian patients

Hepatitis Monthly

Volumn 12, Issue 4, 2012, Pages 265-270

  Shemis, Mohamed Abbas ^a   El Abd, Dina Mohamed ^b   Ramadan, Dalia Ibrahim ^b   El Sayed, Mohamed Ibrahim ^b   Guirgis, Bassem Shenoda ^c   Saber, Mohamed Ali ^a   El Said Azzazy, Hassan Mohamed ^c  

^a Theodor Bilharz Research Institute   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c The American University in Cairo   (Egypt)

Author keywords

Assay; Branched DNA signal amplification; Hepatitis C; Multiplex polymerase chain reaction

Indexed keywords

ARTICLE; COMPARATIVE STUDY; EGYPT; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LINE PROBE ASSAY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SENSITIVITY AND SPECIFICITY; VIRUS CORE;

EID: 84861109787     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.6012     Document Type: Article

References (38)

1. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol. 2005;3(10 Suppl 2):S97-S101.
2. Initiative for vaccine research. World Health Organization. 2007; Available From: www.who.int/entity/vaccine_research/diseases/vector/en/
3. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology. 2000;32(1):111-115.
4. Egyptian Ministry of Health Annual Report. Egyptian Ministry of Health. 2007; Available From: http://www.mohp.gov.eg/default.aspx.
5. Germer JJ, Rys PN, Thorvilson JN, Persing DH. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol. 1999;37(8):2625-2630.
6. Halfon P, Trimoulet P, Bourliere M, Khiri H, de Ledinghen V, Couz-igou P, et al. Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene). J Clin Microbiol. 2001;39(5):1771-1773.
7. Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol. 2008;46(6):1901-1906.
8. Forns X, Maluenda MD, Lopez-Labrador FX, Ampurdanes S, Ol-medo E, Costa J, et al. Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol. 1996;34(10):2516-2521.
9. Forns X, Bukh J. The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin Liver Dis. 1999;3(4):693-716, vii.
10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73(Pt 3):673-679.
11. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35(1):201-207.
12. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74(Pt 11):2391-2399.
13. Stuyver L, Wyseur A, van Arnhem W, Lunel F, Laurent-Puig P, Paw-lotsky JM, et al. Hepatitis C virus genotyping by means of 5'-UR/ core line probe assays and molecular analysis of untypeable samples. Virus Res. 1995;38(2-3):137-157.
14. El-Awady MK, Tabll AA, Atef K, Yousef SS, Omran MH, El-Abd Y, et al. Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J Gastroen-terol. 2006;12(16):2530-2535.
15. Idrees M. Development of an improved genotyping assay for the detection of hepatitis C virus genotypes and subtypes in Pakistan. J Virol Methods. 2008;150(1-2):50-56.
16. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339(6221):237-238.
17. Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Le-frere JJ, et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol. 2007;45(4):1140-1145.
18. Franciscus A. HCV Diagnostic Tools: Genotype, Subtype & Quasi-species. HCSP Fact Sheet. 2010;2(2):1-3.
19. Simmonds P. Hepatitis C virus genotypes. In: Gallin J, Fauci A, Liang T, Hoofnagle J, editors. Hepatitis C, Biomedical Research Reports; 2000.
20. Kamal SM, Nasser IA. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology. 2008;47(4):1371-1383.
21. Rapicetta M, Argentini C, Dettori S, Spada E, Pellizzer G, Gandin C. Molecular heterogeneity and new subtypes of HCV genotype 4. Res Virol. 1998;149(5):293-297.
22. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-973.
23. Abdel-Hamid M, El-Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, Esmat G, et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol. 2007;88(Pt 5):1526-1531.
24. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat. 2007;14(7):460-467.
25. Archer GT, Buring ML, Clark B, Ismay SL, Kenrick KG, Purusotha-man K, et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust. 1992;157(4):225-227.
26. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887-891.
27. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet. 1992;340(8816):427.
28. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993;341(8859):1501-1504.
29. Tanaka E, Kiyosawa K, Sodeyama T, Hayata T, Ohike Y, Nakano Y, et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg. 1992;46(4):460-464.
30. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut. 1995;37(1):105-107.
31. Abdulkarim AS, Zein NN, Germer JJ, Kolbert CP, Kabbani L, Kra-jnik KL, et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg. 1998;59(4):571-576.
32. Blatt LM, Mutchnick MG, Tong MJ, Klion FM, Lebovics E, Freilich B, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat. 2000;7(3):196-202.
33. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol. 1997;78(Pt 6):1341-1347.
34. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994;19(1):13-18.
35. Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, et al. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol. 2001;82(Pt 5):1001-1012.
36. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis. 2000;182(3):698-707.
37. Cabot B, Martell M, Esteban JI, Piron M, Otero T, Esteban R, et al. Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients. J Virol. 2001;75(24):12005-12013.
38. Genovese D, Dettori S, Argentini C, Villano U, Chionne P, Angelico M, et al. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol. 2005;43(4):1902-1909.